Medicare Part D drug prices have increased by an average of 226% since market entry. These 25 drugs are responsible for $80.9 billion in total Part D spending in 2021. The new report (PDF) from AARP’s ...

The brand-name drugs covered under Medicare Part D have nearly doubled in price, and 25 of them are now up 98% since they debuted in the market, a new AARP Public Policy Institute analysis has found.

Medicare Part D spending on 10 diabetes drugs reached $35.8 billion in 2023, a 364% increase from 2019 at $7.7 billion, according to a February report from the Office of Inspector General (OIG). At ...

According to a Kaiser Family Foundation analysis, 22% of Medicare Part D drug spending in 2021 went towards the 10 top-selling prescription drugs alone. In 2021, the 10 top-selling prescription drugs ...

After the recent announcement of the first 10 drugs selected for Medicare price negotiation, much has been discussed about the drugs that were selected and the magnitude of price decreases that can be ...

List prices for the top 25 prescription drugs covered by Medicare Part D have nearly doubled, on average, since they were first brought to market, according to a new AARP report. Moreover, that price ...

The Biden administration plans to announce the first 10 drugs that will be subject to Medicare price negotiation on Sept. 1, with a goal of having the final price in place by 2026. The Centers for ...

The Biden administration released 2 sets of guidance documents for pharmaceutical manufacturers about how it plans to implement the new Medicare Prescription Drug Inflation Rebate Program as required ...

What do I need to know about the difference between Part D and Part B medications? Billing Errors: If a drug is incorrectly billed under the wrong part, claims can be denied. Higher Out-of-Pocket ...